Drug developer Barr Pharmaceuticals Inc. said Thursday it is challenging Cephalon Inc.'s patent on the pain drug Fentora and in turn is being sued to prevent it from marketing a generic version. (AP, 4:30 p.m.)
Invitrogen Corp. , which makes kits that researchers use for gene cloning, said Thursday its second-quarter profit rose 30 percent on higher sales of its drug discovery and research materials. (AP, 2:33 p.m.)
Biotechnology company Celgene Corp. raised its full-year profit and revenue outlook Thursday after reporting a surge in second-quarter sales from its key cancer drug Revlimid. (AP, 2:22 p.m.)
Applied Biosystems Inc. said Thursday its fiscal 2008 fourth-quarter profit fell 1.5 percent, but the maker of life sciences research equipment still topped Wall Street forecasts as it prepares to be bought by rival Invitrogen Corp. (AP, 2:04 p.m.)
Wall Street has so far dealt with a mixed second-quarter report card for biotechnology companies, but shares continue outpacing the broader market on a mix of positive sales results and a bright outlook for buyout potential within the sector. (AP, 12:58 p.m.)